# Citicoline for Bipolar 1 Disorder and Cocaine Dependence

> **NCT00619723** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 130 (actual)

## Conditions studied

- Bipolar Disorder
- Cocaine Dependence

## Interventions

- **DRUG:** Citicoline
- **DRUG:** Placebo
- **BEHAVIORAL:** Cognitive Behavioral Therapy (CBT)

## Key facts

- **NCT ID:** NCT00619723
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2018-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619723, "Citicoline for Bipolar 1 Disorder and Cocaine Dependence". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00619723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*